Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Antidiabetics Market to Cross USD 80.0 Billion by 2022

Market Research Engine
Posted on: 27 Sep 16
Antidiabetics Market to Cross USD 80.0 Billion by 2022

New York, September 27: Market Research Engine has published a new report titled as “Antidiabetics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022”

Global Antidiabetics Market is anticipated to cross USD 80.0 Billion by 2022 growing at a CAGR of more than 9.5 % in the given forecast period.

Download Free Sample Report: https://www.marketresearchengine.com/requestsample/antidiabetics-market

Ant diabetics are the drugs which stabilize the glucose levels in blood. These medicines also control and lower the levels of glucose in blood for diabetic patients. Most common type of antidiabetics is insulin. A periodic shot of insulin generally long acting type is prescribed for diabetic patients to regulate glucose levels.

Increasing number of diabetic patients is increasing the demand for antidiabetics which is a driving factor for antidiabetics market. Increased use of insulin is a growth factor for this market. Insulin leads the global market with the largest market share by revenue and anticipated to have sharp growth. Increase in rates of obesity is obliquely driving the antidiabetics market. North America hold the largest share in antidiabetics market as it holds highest rate of obesity in the world, which is one of the major reason for cause of diabetics.

The global antidiabetics market was valued at USD 41,305.7 million in 2013 and is expected to grow at a CAGR of more than 9.5% during the forecast period.

The global antidiabetics market is segmented based on its product which includes thiazolodinediones, glp-agonists, sulphonylureas, dpp-4 inhibitors, sglt-2, alpha-glucosidase inhibitors, biguanides and meglitinides. The insulin is segmented as rapid acting, long acting, premixed, premixed analog, short acting and intermediate acting. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW).

Browse Full Report:  https://www.marketresearchengine.com/reportdetails/antidiabetics-market

This report provides:

1) An overview of the global market for antidiabetics and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.

3) Identifications of new market opportunities and targeted promotional plans for acetic acid market.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.


The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed Pharmaceuticals, Boehringer Ingelheim, Merck & Co. Inc., Bristol-Myers Squibb, Novo Nordisk, Halozyme Therapeutics, Pfizer and Takeda Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

The Antidiabetics Market has been segmented as below:  

By Types of Insulin

•    Rapid Acting
•    Long Acting
•    Premixed
•    Premixed Analog
•    Short Acting
•    Intermediate Acting

By Product

•    Biguanides
•    Thiazolodinediones
•    GLP-agonists
•    Sulphonylureas
•    DPP-4 inhibitors
•    SGLT-2
•    Alpha-glucosidase Inhibitors
•    Meglitinides

By Geography

•    North America
•    Europe
•    Asia-Pacific
•    Rest of the World (ROW)

For more information:
www.marketresearchengine.com

Editor's Details

John Bay
Market Research Engine
www.marketresearchengine.com
1-855-984-1862
john@marketresearchengine.com

Last updated on: 27/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.